505m1

This competency assessment assesses the following Outcomes):

NU505-1: Analyze epidemiologic data on morbidity and mortality related to acute and chronic disease states.

Individual Preventive Screening

Review the clinician provider guidelines and recommendations from the United States Preventive Services Task Force A and B Recommendations.

For the master's-prepared nurse, knowledge of epidemiology and its application to preventive screening guidelines is important in many clinical areas: administrative, education, and nurse practitioner fields.

Individual patient preventive screenings are ordered as a secondary measure before symptoms occur.

Preventive screenings are recommended based on outcome data from epidemiological studies, that the test is beneficial; based on risk and characteristics of the identified population in the screening guideline.

Select one screening below from the United States Preventive Services Task Force guidelines.

• Abdominal aortic aneurysm
• Breast cancer
• Cervical cancer
• Colon cancer
• Diabetes mellitus Il
• Lung cancer

Condition and Screening

• Define the condition and type of screening

Epidemiology of Condition

• Discuss the epidemiology of the condition in the United States, via three statistical terms. Include the mortality and related morbidity statistics in numerical format and address trends. Include 3 comparisons: related disparities, such as race, sex, age, etc. Clearly state an analysis of the data, identifying gaps and inequities in care. Provide trends and outcomes related to screening benefits in numerical statistics.

Methodology

• Incorporate the described USPSTF guideline development methodology process, (How the guideline was developed).
• Discuss the preventive guideline criteria, the population, and provide details on the screening tool.
• Include detailed risk factors. If there is a risk prediction tool, include this.

Critical Analysis

• Conduct a literature review of the guideline's support used for its development. You may include alternative studies found in more recent literature supporting or offering alternative views.
• Identify and discuss four studies used in the guideline development clearly relating the impact on the guideline criteria for screening, tool, or population etc.
• Identify each study clearly in the naner and cite

Methodology

• Incorporate the described USPSTF guideline development metodology process, (How the guideline
  was developed).
• Discuss the preventive guideline criteria, the population, and provide details on the screening tool.
• Include detailed risk factors. If there is a risk prediction tool, include this.

Critical Analysis

• Conduct a literature review of the guideline's support used for its development. You may include alternative studies found in more recent literature supporting or offering alternative views.
• Identify and discuss four studies used in the guideline development clearly relating the impact on the guideline criteria for screening, tool, or population etc.
• Identify each study clearly in the assignment and cite.

Summary

Provide a  conclusion of the screening guideline, general benefit to the individual, and why it is important.

Format expectations:

• Follow all assessment directions.
• Introduction and conclusion are included.
• Information in paragraphs organized to convey the content to the reader.
• length  should be 3-4 pages of content.
• Follows APA format, reference page, in-text citations, or headings.
• Uses four or more credible peer-reviewed sources.

Master's-prepared nurse educators, leaders, nurse practitioners, and all specialty nursing fields are contributors to health promotion in populations across the life span. You will demonstrate understanding and correct interpretations of preventive screening guidelines. You should be able to apply this knowledge to your specialty focus as it relates to health promotion and epidemiology.